| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 212,1 k € | +3.4% | 205,1 k € | -11.5% | 231,6 k € | -24.8% | 307,8 k € | -1.4% | 312,3 k € | +2.6% | 304,4 k € | -0.8% | 306,8 k € | -3.8% | 318,9 k € | +6.3% | 299,9 k € | -1.5% | 304,6 k € | +5.9% | 287,5 k € | -4.2% | 300,1 k € | +4.1% | 288,3 k € | +1.9% | 282,9 k € | +17.9% | 239,9 k € | -5.3% | 253,3 k € | +2.7% | 246,7 k € | |
| EBITDA | 6,8 k € | +519.6% | 1,1 k € | -96.6% | 32,8 k € | -66.8% | 98,7 k € | +9.2% | 90,4 k € | +30.9% | 69,0 k € | -0.2% | 69,2 k € | -9.1% | 76,1 k € | -17.6% | 92,4 k € | +0.5% | 92,0 k € | -0.8% | 92,7 k € | -16.8% | 111,4 k € | +25.5% | 88,7 k € | -9.9% | 98,5 k € | +143.1% | 40,5 k € | -33.0% | 60,4 k € | -12.2% | 68,8 k € | |
| Operating profit | 1,9 k € | +152.2% | -3,6 k € | -112.6% | 28,2 k € | -69.3% | 91,6 k € | +8.6% | 84,4 k € | +76.1% | 47,9 k € | -2.8% | 49,3 k € | +161.6% | 18,9 k € | -39.9% | 31,4 k € | +5.6% | 29,7 k € | +7.6% | 27,6 k € | -42.3% | 47,8 k € | +160.1% | 18,4 k € | -36.7% | 29,0 k € | +218.6% | -24,5 k € | -319.0% | 11,2 k € | -53.3% | 23,9 k € | |
| Profit/loss | 257,7 € | +104.9% | -5,3 k € | -128.6% | 18,4 k € | -73.5% | 69,4 k € | +12.5% | 61,7 k € | +102.6% | 30,4 k € | +15.3% | 26,4 k € | +2678.1% | 950,8 € | -89.4% | 9,0 k € | -3.7% | 9,4 k € | +28.2% | 7,3 k € | -71.5% | 25,6 k € | +482.0% | -6,7 k € | -332.9% | 2,9 k € | +105.8% | -49,3 k € | -333.6% | -11,4 k € | -619.2% | 2,2 k € | |
| Equity | 82,5 k € | +0.3% | 82,2 k € | -52.3% | 172,5 k € | +12.0% | 154,0 k € | +34.4% | 114,6 k € | +116.5% | 53,0 k € | +135.3% | 22,5 k € | +676.0% | -3,9 k € | +19.6% | -4,9 k € | +65.0% | -13,9 k € | +40.3% | -23,2 k € | +23.9% | -30,5 k € | +45.6% | -56,2 k € | -13.6% | -49,4 k € | +5.5% | -52,3 k € | -1651.8% | -3,0 k € | -135.6% | 8,4 k € | |
| Total assets | 407,6 k € | -13.7% | 472,1 k € | +28.9% | 366,2 k € | +4.0% | 352,0 k € | +7.9% | 326,2 k € | -2.8% | 335,4 k € | -0.7% | 337,7 k € | -14.1% | 393,0 k € | -14.4% | 459,0 k € | -4.9% | 482,8 k € | -9.7% | 534,7 k € | -3.4% | 553,4 k € | -5.7% | 586,5 k € | -10.5% | 655,6 k € | -5.8% | 695,6 k € | +9.5% | 635,4 k € | -6.7% | 681,0 k € | |
| Cash | 51,2 k € | -64.5% | 144,0 k € | +46.8% | 98,1 k € | +26.0% | 77,9 k € | +19.8% | 65,0 k € | -2.2% | 66,4 k € | +39.0% | 47,8 k € | -26.6% | 65,1 k € | -7.8% | 70,6 k € | +50.8% | 46,8 k € | -12.3% | 53,4 k € | -12.5% | 61,0 k € | -5.7% | 64,7 k € | -7.5% | 69,9 k € | +34.4% | 52,0 k € | +32.1% | 39,4 k € | -31.6% | 57,5 k € | |
| Debts | 325,1 k € | -16.6% | 389,9 k € | +101.2% | 193,8 k € | -2.1% | 197,9 k € | -6.4% | 211,5 k € | -25.1% | 282,4 k € | -10.4% | 315,2 k € | -20.6% | 396,7 k € | -14.4% | 463,7 k € | -6.6% | 496,4 k € | -11.0% | 557,9 k € | -4.4% | 583,5 k € | -9.1% | 642,3 k € | -8.8% | 704,5 k € | -5.7% | 747,5 k € | +17.1% | 638,4 k € | -5.1% | 672,6 k € | |
| Staff | 3,7 | 3,7 | 4,1 | 4,5 | 4,9 | 4,9 | 6,1 | 6,3 | 5,1 | 5,1 | 5,9 | 4,3 | 4,6 | 4,6 | 4,6 | 4,4 | 4,4 | |||||||||||||||||
Private limited company · Charleroi · incorporated on 30/11/2007 · 3,7 ETP
Private limited company profitable and well capitalised. Cash position declining (-64.5%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
PHARMACIE YSABEL DEMARET is a Private limited company incorporated in 2007. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Charleroi. It employs on average 3,7 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette